Topics

Wacker Bio licenses its E. coli based production strain to PhaseBio

12:53 EDT 6 May 2019 | Outsourcing-Pharma

Wacker licenses E. coli based production strain to PhaseBio for the manufacture of antibody fragment.

Original Article: Wacker Bio licenses its E. coli based production strain to PhaseBio

NEXT ARTICLE

More From BioPortfolio on "Wacker Bio licenses its E. coli based production strain to PhaseBio"

Quick Search